Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ian Phillips

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophyShuntaro Kagiyama, Keping Qian, Tomoko Kagiyama, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Hypoxia inducible double plasmid system for myocardial ischemia gene therapyYi Tang, MaShira Jackson, Keping Qian, et al.
Neuroscience Letters|June 27, 2009
Angiotensin-induced drinking in rats with hereditary hypothalamic diabetes insipidusA K Johnson, M Ian Phillips, J Mohring, et al.
Biochemical and Biophysical Research Communications|June 20, 2007
A novel two-step procedure to expand cardiac Sca-1+ cells clonallyYao Liang Tang, Leping Shen, Keping Qian, et al.
Molecular and Cellular Endocrinology|May 11, 2018
Exercise training prevents obesity-associated disorders: Role of miRNA-208a and MED13Tiago Fernandes, Diego Lopes Barretti, M Ian Phillips, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotectionM Ian Phillips, Yi Tang, Kai Schmidt-Ott, et al.
Methods in Molecular Medicine|September 18, 2004
Antisense inhibition: oligonucleotides, ribozymes, and siRNAsY Clare Zhang, Meghan M Taylor, Willis K Samson, et al.
Nature Reviews. Drug Discovery|January 1, 2010
Orphan products: an emerging trend in drug approvalsTimothy Coté, Aditya Kelkar, Kui Xu, et al.
Methods (San Diego, Calif.)|November 5, 2002
Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseasesYi Tang, Kai Schmitt-Ott, Keping Qian, et al.
Current Pharmaceutical Design|August 4, 2015
Antisense Therapy for Cardiovascular DiseasesM Ian Phillips, Jessica Costales, Robert J Lee, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophyShuntaro Kagiyama, Keping Qian, Tomoko Kagiyama, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Hypoxia inducible double plasmid system for myocardial ischemia gene therapyYi Tang, MaShira Jackson, Keping Qian, et al.
Neuroscience Letters|June 27, 2009
Angiotensin-induced drinking in rats with hereditary hypothalamic diabetes insipidusA K Johnson, M Ian Phillips, J Mohring, et al.
Biochemical and Biophysical Research Communications|June 20, 2007
A novel two-step procedure to expand cardiac Sca-1+ cells clonallyYao Liang Tang, Leping Shen, Keping Qian, et al.
Molecular and Cellular Endocrinology|May 11, 2018
Exercise training prevents obesity-associated disorders: Role of miRNA-208a and MED13Tiago Fernandes, Diego Lopes Barretti, M Ian Phillips, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotectionM Ian Phillips, Yi Tang, Kai Schmidt-Ott, et al.
Methods in Molecular Medicine|September 18, 2004
Antisense inhibition: oligonucleotides, ribozymes, and siRNAsY Clare Zhang, Meghan M Taylor, Willis K Samson, et al.
Nature Reviews. Drug Discovery|January 1, 2010
Orphan products: an emerging trend in drug approvalsTimothy Coté, Aditya Kelkar, Kui Xu, et al.
Methods (San Diego, Calif.)|November 5, 2002
Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseasesYi Tang, Kai Schmitt-Ott, Keping Qian, et al.
Current Pharmaceutical Design|August 4, 2015
Antisense Therapy for Cardiovascular DiseasesM Ian Phillips, Jessica Costales, Robert J Lee, et al.
Pageof 5